(Washington Examiner) The Food and Drug Administration announced on Tuesday that it would suspend its ban on the sale of Juul vaping products.
The agency said that the administrative stay of its marketing denial order against Juul was a result of “scientific issues” that need additional review. In June, the FDA ordered the vaping company to pull its devices and nicotine liquid pods off shelves, determining that Juul had not shown enough evidence that its products do not hurt public health.
“On July 5, 2022, FDA administratively stayed the marketing denial order. The agency has determined that there are scientific issues unique to the JUUL application that warrant additional review,” the FDA said in a message posted on Twitter.
“This administrative stay temporarily suspends the marketing denial order during the additional review but does not rescind it,” the agency noted, adding that the stay “does not constitute authorization to market, sell, or ship JUUL products.”
On July 5, 2022, FDA administratively stayed the marketing denial order. The agency has determined that there are scientific issues unique to the JUUL application that warrant additional review. (1/3) https://t.co/DHDsFNVe1l
— FDA Tobacco (@FDATobacco) July 5, 2022
